Malignant Nasopharyngeal Neoplasm — Trials

Malignant Nasopharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 261
Recruiting: 139
Ph III recruiting: 56
Growth YoY: +5.2%
Industry share: 9%
Top sponsor: Sun Yat-sen University
Termination share: 24.1%
Trials / 1,000 deaths: 376.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 51–100 of 167 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05483374	The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers(EURACAN)	recruiting	—	13,600	Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER	3	Apr 3, 2026	clinicaltrials
NCT05587543	Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma	recruiting	Early Phase 1	24	Fudan UniversityOTHER	1	Apr 2, 2026